Ralph Corey

Duke Travel and Tropical Medicine Service, Duke University Medical Center, United States of America

G. Ralph Corey, MD Duke University Medical Center, Durham, N.C., USA Duke Clinical Research Institute, Durham, N.C., USA Professor of Medicine and Infectious Diseases Director, Hubert/Yeargan Center for Global Health Acknowledgements: Several members of the Duke Infectious Disease Division assist me with evaluations for Faculty of 1000: Zeina Kanafani, Vance Fowler, Vivian Chu, Tahaniyat Lalani, Chris Cabell Research Interests: · Staphylococcal infections focusing on bacteremia, pneumonia and skin and skin structure infections. · Infectious endocarditis including the International Collaboration on Endocarditis (ICE) · Global Health Associations: · Fellow of the Infectious Disease Society of America (IDSA) · Board Member, International Society of Cardiovascular Diseases (ISCVID)

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Infectious Diseases > Bacterial Infections (since 11 November 2005)

Links

http://www.dukehealth.org/physicians/C35632719C3B97E085256DFD006A90BA?search_highlight=ralph%20corey

All recent recommendations

• 3.0
  What is community-associated methicillin-resistant Staphylococcus aureus?
  Recommended by Ralph Corey
  
• 4.8
  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
  Recommended by Ralph Corey, Richard Wunderink
  
• 3.0
  Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?
  Recommended by Ralph Corey
  
• 8.0
  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.
  Recommended by Melvin Cheitlin, Ralph Corey
  
• 3.0
  Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report.
  Recommended by Ralph Corey
  
• 3.0
  Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus.
  Recommended by Ralph Corey
  
• 3.0
  Prognostic stratification of patients with left-sided endocarditis determined at admission.
  Recommended by Ralph Corey
  
• 3.0
  Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters.
  Recommended by Ralph Corey
  
• 3.0
  High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
  Recommended by Ralph Corey
  
• 3.0
  Increased mortality among elderly patients with meticillin-resistant Staphylococcus aureus bacteraemia.
  Recommended by Ralph Corey
  
• 6.0
  Methicillin-resistant S. aureus infections among patients in the emergency department.
  Recommended by Ralph Corey
  
• 3.0
  Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence.
  Recommended by Ralph Corey
  
• 3.0
  Mortality risk factors in chronic haemodialysis patients with infective endocarditis.
  Recommended by Ralph Corey
  
• 3.0
  A U.S. population-based survey of Staphylococcus aureus colonization.
  Recommended by Ralph Corey
  
• 6.0
  Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils.
  Recommended by Ralph Corey
  
• 3.0
  The serological diagnosis of staphylococcal infective endocarditis.
  Recommended by Ralph Corey
  
• 3.0
  Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
  Recommended by Ralph Corey
  
• 3.0
  Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
  Recommended by Ralph Corey
  
• 3.0
  Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome.
  Recommended by Ralph Corey
  
• 6.0
  Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.
  Recommended by Ralph Corey
  
• 3.0
  Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
  Recommended by Ralph Corey